Hyponatremia during treatment with clomipramine, perphenazine, or clozapine: study of therapeutic drug monitoring samples.
O
O
Spigset
K
K
Hedenmalm
D000328:Adult; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D002997:Clomipramine / Q000009:adverse effects* / Q000097:blood; D003024:Clozapine / Q000009:adverse effects* / Q000097:blood; D016903:Drug Monitoring; D004573:Electrolytes / Q000097:blood; D005260:Female; D006801:Humans; D007010:Hyponatremia / Q000097:blood / Q000139:chemically induced*; D008297:Male; D010546:Perphenazine / Q000009:adverse effects* / Q000097:blood
D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D004573:Electrolytes; D010546:Perphenazine; D003024:Clozapine; D002997:Clomipramine